Neuroendocrine Tumors Market 2020-2026 Huge Growth Opportuniti :: Leading Players – Ipsen Pharma, Regeneron Pharmaceuticals, Mylan N.V, Teva Pharmaceutical Industries Ltd
Global neuroendocrine tumors market is rise gradually to an estimated value of USD 2.80 Billion by 2026 registering a CAGR of 10.2% in the forecast period of 2019-2026. Increasing prevalence of neuroendocrine tumors and accelerating demand of clinical treatment and novel therapies indicates the significant growth of market.
View full press release